By Eddie Beaver ( December 23, 2025, 2:07 PM GMT) -- Janssen has denied a rival's claim that the court should revoke its two patents covering how an injectable form of schizophrenia medication should be given to patients who miss a dose, arguing the patents are inventive and new....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.